Table 2.

Specificities of the monoclonal (mAb) anti-HBGAs used in the study.

	mAb dentification	Specificity	Dilution
Anti-A	#3	A types 3/4	1:10
	#5	A type 2	1:10
	#7	A type 5, ALey > ALeb	1:10
	#21	A types 1-5, ALeb	1:50
Anti-B	#38	B type 2, BLey	1:10
	#39	B type 2	1:10
	#40	B type 2	1:10
	#43	B type 2	1:10
	#49	B types 1-5, BLey	1:10
Anti-H/Lewis	Mbr1	H types 3/4	1:60
	19-OLE	H type 2 > Ley	1:300
	#53	H type 2	1:10
	12-4LE	Ley	1:300
	2-25LE	Leb> Lea	1:100
	7-LE	Lea	1:100
	3E1	Lex	1:10